000 -LEADER |
fixed length control field |
00533nam a2200193Ia 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20211227094753.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180712s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
721658849 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1 |
Author Mark |
LIE |
DDC Edition number |
23 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
LIEBERMAN, Jeffrey A. |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Tasman, Allan |
245 ## - TITLE STATEMENT |
Title |
Psychiatric drugs / |
Statement of responsibility, etc. |
[by] Jeffrey A.Lieberman, Allan Tasman |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Philadelphia |
Name of publisher, distributor, etc. |
W.B.Saunders |
Date of publication, distribution, etc. |
2000 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
ix, 261 p. |
500 ## - GENERAL NOTE |
General note |
Include index. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
psychiatric drugs |
9 (RLIN) |
14005 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
item type |
Books in Reference (R) |